Hudson Bay Capital Management
PFE icon

Hudson Bay Capital Management’s Pfizer PFE Stock Holding History

Hudson Bay Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,300
Closed -$492K – 1576
2025
Q2 		$492K Sell
20,300
-479,700
-96% -$11.2M ﹤0.01% 1088
2025
Q1 		$12.7M Buy
+500,000
New +$13.1M 0.04% 344
2019
Q3 		– Sell
-2,740,400
Closed -$113M – 466
2019
Q2 		$113M Sell
2,740,400
-2,740,400
-50% -$109M 2.58% 7
2019
Q1 		$221M Buy
+5,480,800
New +$219M 2.85% 4

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hudson Bay Capital Management's PFE Position: Q2 2026 in Review

Hudson Bay Capital Management increased its Pfizer (PFE) stake by 383% in Q2 2026, buying an estimated $9.02M and bringing the position to 435,000 shares worth $10.5M. The position accounts for 0.03% of the portfolio, ranked #354.

Hudson Bay Capital Management first reported a position in PFE in Q4 2015 and has held it in 21 quarters since. The position peaked at $142M in Q2 2024. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hudson Bay Capital Management held 435,000 shares of Pfizer worth $10.5M as of Q2 2026.
  • Hudson Bay Capital Management bought 345,000 Pfizer shares in Q2 2026, an estimated $9.02M.
  • Pfizer made up 0.03% of Hudson Bay Capital Management's portfolio in Q2 2026, its #354 holding.
  • Hudson Bay Capital Management first reported a position in Pfizer in Q4 2015 and has held it in 21 quarters since.
  • Hudson Bay Capital Management's Pfizer position peaked at $142M in Q2 2024.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.